TWC
JAZZ icon

TD Waterhouse Canada’s Jazz Pharmaceuticals JAZZ Stock Holding History

TD Waterhouse Canada’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$2.66K – 1979
2024
Q2 		$2.66K Buy
+25
New +$2.75K ﹤0.01% 1604
2023
Q3 		– Sell
-18
Closed -$2.23K – 1762
2023
Q2 		$2.23K Hold
18
– – ﹤0.01% 1529
2023
Q1 		$2.62K Buy
18
+4
+29% +$592 ﹤0.01% 1483
2022
Q4 		$2.19K Hold
14
– – ﹤0.01% 1477
2022
Q3 		$1.9K Hold
14
– – ﹤0.01% 1509
2022
Q2 		$2.22K Hold
14
– – ﹤0.01% 1529
2022
Q1 		$2.22K Hold
14
– – ﹤0.01% 1578
2021
Q4 		$1.81K Buy
+14
New +$1.84K ﹤0.01% 1599

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

TD Waterhouse Canada's JAZZ Position: Q3 2024 in Review

TD Waterhouse Canada sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 25 shares — an estimated $2.66K sold.

TD Waterhouse Canada first reported a position in JAZZ in Q4 2021 and held it in 8 quarters. The position peaked at $2.66K in Q2 2024. 478 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • TD Waterhouse Canada reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 25 Jazz Pharmaceuticals shares in Q3 2024, an estimated $2.66K.
  • TD Waterhouse Canada first reported a position in Jazz Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • TD Waterhouse Canada's Jazz Pharmaceuticals position peaked at $2.66K in Q2 2024.
  • 478 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on TD Waterhouse Canada's 13F filing for Q3 2024, filed 12 Nov 2024.